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Cell cycleTransformed and tumoral cells share the characteristic of being able to proliferate even when external calcium
concentration is very low.We have investigatedwhether Human Embryonic Kidney 293 cells, human hepatoma
cell Huh-7 and HeLa cells were able to proliferate when kept 72 h in complete culture mediumwithout external
calcium. Our data showed that cell proliferation rate was similar over a range of external calcium concentration
(2 μMto1.8 mM). Incubation in the absence of external calcium for 72 hhadno signiﬁcant effect on endoplasmic
reticulum (ER) Ca2+ contents but resulted in a signiﬁcant decrease in cytosolic free calcium concentration in all 3
cell types. Cell proliferation rateswere dependent onOrai1 andOrai3 expression levels inHEK293 andHeLa cells.
SilencingOrai1 or Orai3 resulted in a 50% reduction in cell proliferation rate. Flow cytometry analysis showed that
Orai3 induced a small but signiﬁcant increase in cell number inG2/Mphase. RO-3306, a cdk-1 inhibitor, induced a
90% arrest in G2/M reversible in less than 15 min. Our data showed that progression through G2/M phase after
release fromRO-3306-induced cell cycle arrestwas slower in bothOrai1 andOrai3 knock-downs. Overexpressing
Orai1, Orai3 and the dominant negative non-permeant mutants E106Q-Orai1 and E81Q-Orai3 induced a 50% in-
crease in cell proliferation rate in HEK293 cells. Our data clearly demonstrated that Orai1 and Orai3 proteins are
more important than calcium inﬂux to control cell proliferation in some cell lines and that this process is probably
independent of ICRAC and Iarc.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The relation between cell proliferation and calcium channel expres-
sion is now well established and recent reviews have summarized the
nature of calcium channels involved and emphasized their role in path-
ophysiological proliferation, thus revealing their oncogenic potential
[1–4]. Normal and tumoral tissues often display different calcium chan-
nel expression and we recently showed that stronger levels of the
TRPC6 cation channel are observed speciﬁcally in area of tumoral
human livers [5]. Store-operated calcium entry (SOCE), activated fol-
lowing intracellular calcium store depletion [6], is clearly themajor cal-
cium entry pathway involved in cancer [7]. Therefore, calcium channels
are nowadays considered as potential targets for anticancer therapies, Ligue Contre le Cancer (TC).
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ights reserved.with only a few drugs undergoing clinical tests. Carboxyamidotriazole
(CAI), a calcium channel blocker originally described as a tumor repres-
sor in several cancers [8,9] and now used in lung cancer phase III clinical
trials [10], was also recently shown to inhibit mitochondrial activity in
the same range of concentrations [11]. Other blockers include verapa-
mil, diltiazem, nifedipine, amlodipine, mibefradil, TH-1177, 2-APB, and
SK&F 96365 but none of these drugs has clear selectivity for one type
of calcium channels [12,13].
If the role of calcium channels seems to be rather clear, the need for
external calcium for cell proliferation can be questioned [12,13]. During
the seventies, several scientists have studied the dependence on exter-
nal calcium of normal and transformed cells [14–16] and they
established that, while normal cells need external calcium to proliferate,
transformed cells are less sensitive [14,17,18]. In fact, transformed cells
proliferate even in the presence of 20 μM external calcium with maxi-
mum proliferation rates achieved in the range of 50 to 100 μM while
non-tumorigenic cells had higher requirement (500 to 1000 μM).
The need for calcium inﬂux during cell cycle is not deﬁnitively set-
tled in mammalian cells. Indeed, it is known that, ﬁrst, blockade of cell
cycle was associated to a decrease in SOCE amplitude [19,20], and sec-
ond, calcium channel blockers inhibited cell proliferation [21]. SOCE is
Table 1
siRNA and primers sequences respectively used for silencing protein expression and
detection in qPCR experiments.
siRNA sequence
Si Luc 5′-CUUACGCUGAGUACUUCGA(dTdT)-3′
Si Orai1 5′-UGAGCAACGUGCACAAUCU(dTdT)-3′
Si Orai3 5′-UUGAAGCUGUGAGCAACAU(dTdT)-3′
Primers sequence
Orai1 5′-ATGGTGGCAATGGTGGAG-3′ 5′-CTGATCATGAGCGCAAACAG-3′
Orai3 5′-GGCCAAGCTCAAAGCTTCC-3′ 5′-CCTGGTGGGTACTCGTGGT-3′
GAPDH 5′-ATCTCTGCCCCCTCTGCT-3′ 5′-GCAGGAGGCATTGCTGAT-3′
HPRT 5′-GGCGTCGTGATTAGTGATGAT-3′ 5′-CGAGCAAGACGTTCAGTCCT-3′
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treatment in calcium imaging experiments or in whole-cell voltage-
clamp cells using Ca2+-buffered solution and stable InsP3 receptor ago-
nists [6]. However, there is no clear evidence that SOCE is activated in
cells continuously stimulatedwith growth factors. Indeed, calcium tran-
sients, and probably transient ER Ca2+ store depletion, were recorded
during fertilization ormeiosis in oocytes but this is far from clear during
mammalian cell cycle.
The relation between calcium channel expression and cell cycle is
better documented. First, cell cycle arrest, whatever the cell cycle
phase and the mechanism used to induce this blockade, induced a
clear decrease in SOCE amplitude [13]. Second, knocking down Orai,
TRPC or TRPM channels resulted in cell cycle arrest [13]. Third, ampli-
tude of SOCE and the archetype current ICRAC is modulated during cell
cycle [22] and is totally inhibited duringmitosis due to several potential
mechanisms including internalization [23,24], phosphorylation [25] or
decreased expression [20].
Here, we have investigated whether external calcium was needed
for cell proliferation, mitosis and cell cycle progression. HEK293 cells,
human hepatoma cell line Huh-7 and HeLa cells were used to establish
the differential roles of calcium channels and calcium inﬂux in cell
division.
2. Materials and methods
2.1. Cell culture
HEK293 stably transfected with the human m3 muscarinic receptor
(HEKm3), human hepatoma cell line Huh-7 and HeLa cells were cul-
tured as described before [11] in DMEMwithGlutamax-I supplemented
with fetal calf serum (FCS, 10%), penicillin (200,000 U/ml) and strepto-
mycin (100 μg/ml) (Life Technologies, Cergy-Pontoise, France).
2.2. Cell proliferation
Cell proliferation rates were determined using two separate
methods. Cells were seeded in 96-well plates for 3 days before medium
substitution. Medium was renewed every day and proliferation moni-
tored for 3 days in DMEM without Ca2+ supplemented with EGTA
150 μM, fetal calf serum (FCS, 10%), penicillin (200,000 U/ml) and
streptomycin (100 μg/ml) and Glutamax-I (Life Technologies, Cergy-
Pontoise, France). Proliferation rates were determined as described be-
fore [5] or bymeasuring cell number in cells kept 3 days in different ex-
ternal Ca2+ concentrations. Cell viability was assessed using Trypan
Blue staining of dead cells.
2.3. Mitotic index
Cells were collected by trypsinization, resuspended in 300 μl PBS–
EDTA (5 mM) and ﬁxed with 700 μl absolute ethanol at−20 °C over-
night. Cells were washed twice with wash solution (PBS/0.05% Triton
X-100). Cells were then incubated in staining solution (PBS/0.2% Triton
X-100/2% FCS) containing 1 μg/ml anti-phospho-Histone H3 (Ser10;
Millipore 05-806) for 2 h at 4 °C. Cells were washed twice with wash
solution and secondary antibodies (anti-mouse IgG coupled to Alexa
Fluor-488) diluted at 1/2000 were incubated with cells for 2 h at 4 °C
in the dark. Afterwards, cells were washed out 3 times at RT for a total
of 30 min. Finally, cells were resuspended in PBS and treated with ribo-
nuclease at a ﬁnal concentration of 2 μg/ml for 30 min and stained with
propidium iodide at a ﬁnal concentration of 25 μg/ml. The stained sam-
ples were analyzed using a Becton Dickinson FACScan cytoﬂuorometer.
2.4. Calcium measurements
Cytosolic free calcium concentration ([Ca2+]i) and thapsigargin-
induced responses were monitored in a multiplate reader BertholdTriStar (Berthold France SAS, Thoiry, France). Cells were plated in
24-well plates and incubated for 72 h in complete DMEM in the
presence or absence of external Ca2+. Cells were loaded with 4 μM
ﬂuo4-AM for 45 min then washed with recording medium containing
(mM) NaCl 116, KCl 5.6, MgCl2 1.2, NaH2PO4 1, NaHCO3 5, Hepes
20 (pH 7.3) supplemented with 1.8 mM Ca2+ or 150 μM EGTA.
Thapsigargin (1 μM) was added in the absence of external Ca2+ and
areas of the responses calculated using Origin. Recordings were
performed at 37 °C and ﬂuorescence signals calibrated by successive
additions of 5 mM digitonin containing 5 mM Ca2+, and 50 mM
EGTA (pH 7.3 NaOH). [Ca2+]i was determined using the equation
Kd*((F-Fmin)/(Fmax-F)), with Kd of ﬂuo4 for Ca2+ taken as 345 nM,
Fmax and Fmin, the maximum and minimum ﬂuorescence signals
after digitonin and EGTA addition respectively.
2.5. Cell cycle analysis
Cells were seeded for at least 24 h before transfection with siRNA.
Cells were treated for 24 h with 10 μM RO-3306 on the next day. Cells
were thenwashed in completemediumwithout RO-3306 for the period
of time indicated. The same protocol was used for non-transfected cells
with two washes in Ca2+-free solutions when needed. Cells were har-
vested andwashed with phosphate-buffered saline and ﬁxed overnight
with 70% ice-cold ethanol at−20 °C. The ﬁxed cells were stainedwith a
solution containing Propidium Iodide (25 μg/ml), RNase A (2 μg/ml)
and Triton X-100, and then analyzed with a Becton Dickinson FACScan
cytoﬂuorometer. G0/G1, S and G2/M phases were assessed by ﬁtting
the cell distribution using ModFit software (Verity Software House,
ME, USA). 10% FCS contains about 100 μM (measured in fura2 solution,
data not shown) close to values reported in the literature [26] and we
therefore estimated the Ca2+ concentration of the Ca-free medium to
approximately 140 μM as Ca2+-free DMEM medium contains about
40 μM free Ca2+. After the addition of 150 μM EGTA, free calcium was
therefore calculated to 2 μM using MaxChelator (Ca–Mg–ATP–EGTA
Calculator v1.0 http://maxchelator.stanford.edu). Data acquisition and
data analysis were performed on the IFR94 Cytometry Facility (Growth
and Signalling Research Center, Université Paris 5, Paris, France).
2.6. Transfection
SiRNAwas transfectedwithHiPerfect lipofectant (Qiagen). Transfec-
tion protocols were performed following the manufacturer's instruc-
tions. SiRNA sequences (Table 1) against Orai1 and Orai3 were
previously validated [20,27]. Control experiments were performed by
transfecting a speciﬁc siRNA against Luciferase (noted siLuc).
2.7. Reverse-transcription and real-time PCR analysis
Total RNAwas extracted using the Trizol method (Invitrogen, Cergy
Pontoise, France) according to the manufacturer's instructions. After a
DNase I (Invitrogen) treatment, 2 μg of total RNA was reverse tran-
scribed into cDNA at 42 °C using random hexamer primers (Applera)
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pression levels of PCR products were quantiﬁed by real-time quantita-
tive PCR on a Cfx C1000 system (Biorad). For each reaction, 5 μl of a
20 times diluted cDNA was placed in a ﬁnal reaction mixture of 15 μl
containing 7.5 μl of 2× Evagreen Master Mix (Applied Biosystems)
and 250 nM primer pairs. The housekeeping gene glyceraldehyde-
3phosphate dehydrogenase (GAPDH) and hypoxanthine–guanine
phosphoribosyltransferase (HPRT) (see sequence in Table 1) were
used as an endogenous control to normalize variations in RNA extrac-
tions, the degree of RNA degradation and variability in RT efﬁciency.
Dissociation curve was done to assess speciﬁcity of ampliﬁcation. The
comparative Ct method was used to quantify gene expression.2.8. Western-blots
An ice-cold buffer (pH 7.2) containing 10 mM PO4Na2/K buffer,
150 mM NaCl, 1 g/100 ml sodium deoxycholate, 1% Triton X-100, 1%
NP40, a mixture of protease inhibitors (Sigma-Aldrich), and a phospha-
tase inhibitor (sodium orthovanadate; Sigma-Aldrich) was applied to
previously PBS washed cells in dishes. After 30 min incubation on ice,
the protein extract was transferred to 1.5 ml tubes and subjected to
sonication. After 10 min of centrifugation at 15,000 g, the pellet was
transferred into a clean tube prior to a determination of the protein con-
centration using a BCA Protein Assay (Pierce). 50 μg of total proteinwas
loaded onto a 12% polyacrylamide gel before an SDS-page was per-
formed. After electrophoresis, proteins were transferred to a PVDF
membrane using a semi-dry electroblotter (Bio-Rad). The membrane
was blocked in a TNT +3% (W/V) milk (15 mM Tris buffer, pH 8,
140 mM NaCl, 0.05% Tween 20, and 3% non-fat dried milk) for 30 min
at room temperature, then incubated with primary Orai1 antibody
(O8264; Sigma-Aldrich) diluted (1/1000) in TNT +1% milk for over-
night at +4 °C. After three washes in TNT, the membrane was soaked
in secondary antibody diluted in TNT+1%milk for 1 h at room temper-
ature. The membrane was processed for chemiluminescence detectionCTRL
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Fig. 1. Cell cycle analysis by DNA content estimation with ﬂow cytometry in HEK293 cells. Left:
10 μM RO-3306, and 1 h after RO-3306 washout (1 h wo). Numbers indicate the percentage of
different phases of the cell cycle in control cells (CTRL), in cells treated for 24 h with 10 μM ROusing Luminata Forte Western HRP Substrate (Millipore) according to
the manufacturer's instructions.
2.9. Evaluation of half-time decay of cell cycle release
Quantiﬁcation of speed release from cell cycle arrest was evaluated
as the time at which half of the maximal proportion of cells was ex-
cluded from G2/M (cell cycle experiment) or M phase (Mitotic index
experiment), and was deﬁned as the half-time decay, τ(1/2). Values
representing the proportion of cells in G2/M or M phase over time
were plotted as the function %cell = f(t). τ(1/2) was estimated graphi-
cally on interpolated curves as f(t) = (%max − %min) / 2; %max is the
proportion of cells in G2/M or M phase 30 min after the release of cell
cycle arrest; and %min is the minimal proportion of cells in G2/M or M
phase after the release of cell cycle arrest.
2.10. Statistics
An unpaired Student t test was used and results are expressed as
means ± s.e.m., with P b 0.05 (*), P b 0.01 (**) and P b 0.001 (***).
3. Results
The inﬂuence of calcium channels on cell cycle progression and mi-
tosis was investigated by using the cyclin-dependent kinase 1 inhibitor
RO-3306 [28]. We previously showed that 10 μM RO-3306 for 24 h re-
sulted in a massive blockade in G2/M and a large decrease in SOCE am-
plitude in HEK293 cells [20]. SOCE was fully recovered within 4 h after
RO-3306 wash off and we have investigated here the kinetics of G2/M
exit, mitosis and G0/G1 entry using cell cycle analysis with ﬂow cytom-
etry in HEK293 and HeLa cells. 24 h in the presence of 10 μM RO-3306
induced a cell cycle arrest with 89.8 ± 0.9% (n = 12) of HEK293 cells
(Fig. 1) and 88.3 ± 0.9% (n = 8)of HeLa cells in G2/Mphase conﬁrming
previous work [28]. We then monitored the release from blockade over0
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Fig. 2. Cell cycle analysis by DNA content estimation with ﬂow cytometry in HEK293 (A)
and HeLa cells (B) in Ca-free medium. Cell cycle progression was monitored after release
from RO-3306 induced cell cycle arrest. Cells were treated for 24 h with 10 μM RO-3306
(t = 0) and released in complete DMEM containing 1.8 mM Ca2+ (black trace) or Ca-
free complete DMEM supplemented with Glutamax and 150 μM EGTA (red trace) with
G0/G1 (top), S (middle) and G2/M (bottom). HEK293 and HeLa cells displayed a similar
pattern in both conditions.
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changed 30 min after release but the cell number in G0/G1 started to
increase after 1 h, with a parallel decrease in the proportion of cells in
G2/M. The simultaneous increase in G0/G1 and decrease in cell number
in G2/M were observed for 8 h with no change in S phase. G0/G1 in-
creased from 2.8 ± 0.6% in the presence of RO-3306 to 70.5 ± 1.4
(n = 12) 8 h after release from cell cycle arrest while cell number in
G2/M decreased from 89.8 ± 0.9% to 22.5 ± 2.7 (n = 12) in the same
conditions. One issue of cell cycle analysis with ﬂow cytometer is the in-
ability to discriminate between G2 and M phases. It is thus almost im-
possible to determine whether the delay of cell exit from G2/M phase
is dependent onG2 transition time,M transition timeor both.We there-
fore calculated the decay of mitotic index after RO-3306 removal. It has
been previously demonstrated that R0-3306-induced G2/M-phase-
arrested cells are actually arrested in G2 phase as they did not showed
Ser10 phosphorylation of histone H3 [28]. This latter has been demon-
strated to occur from prophase to telophase of mitosis. As seen in Sup-
plemental Fig. 1, we showed that the half-time decay (τ(1/2)) of the
relative mitotic index is similar to the half-time decay of G2/M-phase-
arrestedHEK293 cells since both are reached 1 h after R0-3306 removal.
This suggests that, although R0-3306 induced cell cycle arrest in G2
phase, cells enter mitosis several minutes after R0-3306 removal. Con-
sequently, G2/M cell population detected by DNA content analysis
with ﬂow cytometry in cells treated with RO-3306 could be considered
as M cell population from 30 min to 4 h after R0-3306 removal.
Cell cycle analysis by DNA content estimation with ﬂow cytometry
was also used to study the role of external Ca2+ on mitosis and
cell cycle progression in HEK293 and HeLa cells. Cells were blocked in
G2/M phase using RO-3306 and released either in Ca2+-containing or
Ca2+-free medium in the presence of 10% FCS and 150 μM EGTA. Cell
cycle progression was monitored over a time period of 24 h in
HEK293 and HeLa cells. Exit from G2/M arrest and mitosis was insensi-
tive to external Ca2+ in both HEK293 and HeLa cells (Fig. 2A and B).
HEK293 and HeLa cells were able to progress through all the phases at
the same speed in the absence or presence of external Ca2+ with a
cell cycle length of about 20–22 h (Fig. 2A and B).
We also checked whether cell proliferation was blocked in the ab-
sence of external Ca2+. HEK293, HeLa and Huh-7 cells were seeded in
complete culture medium then incubated for another 3 days in the
presence or absence of external Ca2+. Our data showed (Fig. 3A) that in-
cubating all 3 cell types in the absence of external Ca2+ had no effect on
cell proliferation. The dependence of external Ca2+ concentration was
also investigated and no signiﬁcant difference was observed over a
range from 2 μM up to 1800 μM (Fig. 3B). Cell viability was similar in
all conditions and ranged from 95 to 99% in all cell types.
Incubating the cells for 72 h in the absence of external Ca2+ could
result in a decrease in ER Ca2+ content and [Ca2+]i. ER Ca2+ content
was assessed by measuring the area under the thapsigargin-evoked
rise in [Ca2+]i in the absence of external Ca2+ as described before
[29]. Our data showed no signiﬁcant change in ER Ca2+ content in
Huh-7, HeLa and HEK293 cells in the presence or absence of external
Ca2+ after 72 h (Fig. 4A) while [Ca2+]i was decreased from
113 ± 13 nM (n = 15) to 20 ± 3 nM (n = 30), 108 ± 9 nM
(n = 20) to 90 ± 4 nM (n = 54), and 82 ± 6 nM (n = 25) to
7 ± 1 nM (n = 9) in Huh-7, HeLa and HEK293 cells respectively
(Fig. 4B).
Several studies have clearly demonstrated that cell proliferation is
related to calcium channel expression [13]. The apparent contradiction
between these observations and our data led us to investigate the role
of Orai1 and Orai3 on cell cycle progression and cell proliferation in
HEK293 cells. Cell cycle analysis by DNA content estimation with ﬂow
cytometry was performed after transfection with siOrai1 (50 nM),
siOrai3 (75 nM) and both siOrai1 and siOrai3 (25 and 75 nM respec-
tively). Knock-down efﬁciency of these siRNAs was performed with
quantitative PCR (Supplemental Fig. 2). Our results showed that siOrai3
and siOrai1 + 3 induced a signiﬁcant increase in cell number in G2/Mphase and that siOrai1 + 3 induced a signiﬁcant decrease in S phase
(Fig. 5). G2/M was increased from 26.6 ± 1.3 (n = 15) in control cells
to 31.5 ± 1.3 (n = 13) and 35.1 ± 1.6 (n = 10) in siOrai3 and
siOrai1 + 3 cells respectively. S phase was decreased from 25.7 ± 1.4
(n = 15) in control cells to 20.3 ± 1.6 (n = 10) in siOrai1 + 3 cells.
Exit frommitosis and cell cycle progression wasmonitored in siRNA
transfected HEK293 cells. Cells were blocked in G2/M after 24 h in the
presence of 10 μMRO-3306 then released in completeDMEM. Transfec-
tionwith siRNA against Orai1, Orai3 and bothOrai1 andOrai3 had no ef-
fect on RO-3306 induced cell cycle arrest in G2/M (Fig. 5). Re-entry in
cell cycle was checked 4 h and 16 h after release from blockade. A de-
crease expression in Orai1, Orai3 or both, resulted in a slower increase
in G0/G1 and a decrease in G2/M phases respectively 4 h after release
from blockade. The number of cells in G0/G1 was reduced from
43.8 ± 1.1 (n = 12) in siLuc transfected control cells to 28.9 ± 3.1
(n = 14), 25.4 ± 2.6 (n = 11) and 29.3 ± 4.1 (n = 7) in siOrai1,
siOrai3 and both siOrai and siOrai3 respectively. In contrast, the number
of cells in G2/M remained higher in siOrai1 (64.6 ± 2.8, n = 16),
siOrai3 (66.7 ± 3.0, n = 11) and both siOrai and siOrai3 (65.4 ± 4.4,
n = 7) than in siLuc cells (46.4 ± 1.4, n = 12). A very different pattern
was observed 16 h after release fromblockade. Indeed, siLuc transfected
cells progressed along the cell cycle and entered S phase with less cells
CT
RL
Ca
0E
GT
A
Ca
0
Ca
01
00
Ca
05
00
Ca
01
00
0
Ca
01
80
0
0
4
8
12
CT
RL
Ca
0E
GT
A
Ca
0
Ca
01
00
Ca
05
00
Ca
01
00
0
Ca
01
80
0
0
4
8
CT
RL
Ca
0E
GT
A Ca
0
Ca
01
00
Ca
05
00
Ca
01
00
0
Ca
01
80
0
0
4
8
12
3
6
0
6
12
A
B
HEK293 HeLa
0 1 2 30 1 2 3
HEK293 HeLa Huh-7
In
cr
ea
se
 in
 c
el
l n
um
be
r (
xfo
ld)
In
cr
ea
se
 in
 c
el
l n
um
be
r (
xfo
ld)
Fig. 3. Cell proliferation in HEK293, Huh-7 and HeLa cells. (A) HeK293 andHeLa cells were incubated for 3 days in the presence (solid) or absence (dash) of external Ca2+ as in Fig. 2. Cells
were counted every day and data are summary of 3 separate experiments done in triplicate. (B) HEK293, Huh-7 and HeLa cells were incubated for 3 days in Ca-free DMEMmedium sup-
plemented with 10% FCS, Glutamax and 150 μM EGTA (Ca0EGTA), no EGTA (Ca0), 100 μM CaCl2 (Ca0100), 500 μM CaCl2 (Ca0500), 1000 μM CaCl2 (Ca01000) and 1800 μM CaCl2
(Ca01800). Cells were counted just before incubation (CTRL) in these different culture media and results are expressed as fold increase from this initial value. Histograms summarized
cell numeration in 3 separate experiments done in triplicate. No signiﬁcant difference was observed in all conditions.
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Orai1 and Orai3 knock-down conditions, probably due to the delayed
re-entry in G0/G1 phase. A marked difference was observed in G2/M
phase as cells remained for a longer time in this phase in the absence
of Orai3 (54.9 ± 5.3, n = 11) or both Orai1 and Orai3 (48.3 ± 4.8,
n = 8) than in siOrai1 alone (32.1 ± 2.0, n = 16). This strongly0
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in the absence of Orai1 or Orai3 using the same method as described
above. While τ(1/2) of the relative mitotic index after RO-3306 removal
was about 1 h in siLuc transfected HEK293 cells, τ(1/2) in Orai1 or
Orai3 knock-downs conditions were 1 h50 and 1 h29, respectively0
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Fig. 5. Flow cytometry analysis of cell cycle after down-regulation of Orai1 and Orai3
calcium channels in HEK293 cells. Cells were transfected with siRNA against luciferase
(black column), Orai1 (white), siOrai3 (dark gray) and both Orai1 and Orai3 (light gray)
and cell cycle analyzed 3 days after transfection. Cell cycle was determined in control con-
ditions (CTRL), after 24 h in the presence of 10 μMRO-3306, 4 (4 h wo) and 16 (16 hwo)
after release from cell cycle arrest. The 3 sets of histograms represent the G0/G1 (top),
S (middle) and G2/M (bottom) phases and summarized data in 3–4 separate experiments
with n ranging from 11 to 12 (CTRL), 14 to 16 (siOrai1), 9 to 11 (siOrai3) and 7 to 8
(siOrai1 + 3). *P b 0.05; **P b 0.01, ***P b 0.001.
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phase release (cell cycle analysis), strongly suggesting that Orai3 and
in a lesser extent Orai1, are essential in mitosis transition.
The relation between Orai1 andOrai3 expression levels and cell pro-
liferation was also investigated. Knock-down and overexpression ex-
periments were performed to assess the role of these two calcium
channels.We already showed that siRNA against Orai1 resulted in a dra-
matic reduction in cell proliferation rate [20]. Here, we obtained a 50%
decrease of HEK293 cell number after a 48–72 h transfection with
siRNA targeting either Orai3 or both Orai1 and Orai3 (Fig. 6A). Similar
results were obtained in HeLa cells with siRNA against Orai1, Orai3 or
both Orai1 and Orai3 (Fig. 6A). Opposite results were observed when
Orai1 or Orai3 channels were overexpressed in HEK293 cells. Our re-
sults showed ﬁrst that cell number was increased by 30% 72 h after
transfection as compared to controls and second, that cell number in-
creased by 8 fold within 72 h indicating that cell cycle duration was re-
duced to less than 16 h in overexpressing conditions as compared to
20–24 h in control conditions (Figs. 2A, 3A and 6B). Cell proliferation
was also monitored in the presence of the dominant negative non-
permeant mutants E106Q (Orai1) and E81Q (Orai3). It has previouslyshowed that overexpressing E106Q and E81Q mutants resulted in the
inhibition of Icrac and Iarc respectively [30,31]. Our data showed that
cell proliferation rates in the presence of these mutants were increased
to the same levels as for Orai1 and Orai3 channels strongly suggesting
that the observed effects were independent of any increase in calcium
currents. Cell cycle analysis showed a small but signiﬁcant decrease in
G2/Mphase in Orai3 overexpressingHEK293 cells (Fig. 6C). Overexpres-
sion of both mutants was conﬁrmed by qPCR (Supplemental Fig. 4) and
western-blots (Supplemental Fig. 5) for Orai1.
4. Discussion
The intimate relation between calcium channels expression and cell
proliferation is well documented [2,3,13,32]. However, our present re-
sults showed that it is the Orai proteins themselvesmore than its intrin-
sic primary function that are required for cell proliferation in some cell
types. Indeed, both Orai1 and Orai3 channels are clearly involved in
ICRAC and Iarc activity as already shown in HEK293 cells [30,33] but we
assume that this may be incidental in the control of cell proliferation.
In one hand, knocking down Orai channels as well as other channels in-
volved in SOCE such as TRPC channels resulted in a reduced cell prolif-
eration and cell cycle arrest [13]. On another hand, blocking cell
proliferation resulted in a decrease calcium channel expression as previ-
ously shown for Orai1 in HEK293 [20]. Thus, blocking cell proliferation
induces a decrease in SOCE as calcium channel expression is decreased
but it is still unclear whether SOCE is really needed for cell proliferation.
There is also evidence that knocking down STIM1 has virtually no effect
on cell proliferation in an increasing number of cell typeswhile it almost
totally inhibits SOCE activity [20,34–37]. Knocking-down Orai3 was
much more effective than reducing external calcium concentration in
reducing cell proliferation in MCF-7 cells [38]. It was also shown that
knocking down TRPC1 or TRPC4 in human endothelial cells reduced
cell proliferation rate but had no effect on SOCE amplitude [34]. Finally,
on the basis of our results demonstrating the lack of effect of external
calcium in Huh-7 cell proliferation, our own previous work on the role
of TRPC6 in Huh-7 proliferation could be interpreted as a result of chan-
nel expression rather than calcium inﬂux amplitude [5]. Thus, the two
processes, cell proliferation and calcium inﬂux, could be unconnected,
questioning the source of calcium triggering the Ca2+ transients ob-
served at different stages of the cell cycle [39,40]. The other evidence
in favor of an effect of calcium inﬂux on cell proliferation comes
from the use of calcium channel blockers. We, and other laboratories,
have shown that calcium channel blockers, such carboxyamidotriazole
or 2-APB, totally blocked cell proliferation [21,41] but it is also clear
that at the concentrations used in these studies that both blockers
may affect ER Ca2+ release mechanisms.
Cell proliferation and cell cycle arrest depend on Orai1 and Orai3 ex-
pression levels. The data here showed that Orai3 or both Orai1 and
Orai3 silencing signiﬁcantly increased cell number in G2/M and blocked
cell proliferation.We previously described a small increase in cell num-
ber in G2/M in the presence of siOrai1 [20] but in this new set of exper-
iments, this increase was no longer statistically different. Other studies
have described a G0/G1 decrease and G2/M increase in Orai1 silencing
experiments [34] and cell proliferation inhibition in several cell types
[13] and an increase in cell number in G0/G1 and cell proliferation inhi-
bition in overexpressing conditions [42]. Orai3 silencing has no effect on
vascular smooth muscle cell proliferation [43] but induced an increase
in cell number in G0/G1 and cell proliferation inhibition inMCF-7 breast
cells while it has no effect in another breast cell line MCF-10A [38].
Our data showed that cell proliferation was signiﬁcantly increased in
Orai1 and Orai3 overexpressing experiments. Overexpression of non
permeant mutants E106Q and E81Q for Orai1 and Orai3 respectively
suggested that this was independent of calcium inﬂux as both mutants
have been shown to block Icrac (E106Q) [31] or Iarc (E81Q) [30]. This
increase in cell proliferation rates seen when overexpressing Orai chan-
nels and their respective mutants, has no signiﬁcant effects on cell cycle
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Fig. 6. Cell proliferation, cell cycle analysis and Orai channel expression A) Cell proliferation in SiRNA Orai3 and both Orai1 and Orai3-transfected HEK293 cells and in siRNA Orai1, Orai3
and both Orai1 and Orai3-transfected HeLa cells. Cells were plated and transfected the following day with siRNA against luciferase (100 nM, black), Orai1 (25 nM, white), Orai3 (75 nM,
gray) or both 25 nMOrai1 and 75 nMOrai3 (dark gray). Cell numberwas determined 72 h after transfection and graphs are summarizing the results obtained in 3 separate experiments.
P b 0.001 for all conditions compared to siLuc. B)HEK293 cellswere transfected then trypsinized 12 h later and seeded in 60 mmdishes. Cellswere transfectedwith empty plasmidMO70
(black), Orai1 (white), E106Q Orai1 (light gray), Orai3 (gray) and E81Q Orai3 (dark gray). Cells were counted 30, 54 and 78 h after transfection (days 1, 2 and 3 respectively) and results
were normalized to cell numeration at day 1. Cell number was determined every day in triplicates for 3 days, and graphs are summarizing the results obtained in 4 separate experiments.
P b 0.001 for all conditions compared toMO70 at day 2 and day 3. C) Flow cytometry analysis of cell cycle in the presence of Orai1, Orai3 and their respective mutants E106Q and E81Q in
HEK293 cells. Cells were transfected with empty plasmid MO70 (black), Orai1 (white), E106Q Orai1 (light gray), Orai3 (gray) and E81Q Orai3 (dark gray) and cell cycle analyzed 3 days
after transfection. The 3 sets of histograms represent theG0/G1 (top), S (middle) andG2/M (bottom) phases and summarized data in 4 separate experimentswith n = 12 in all conditions.
No signiﬁcant difference was observed compared to MO70 except in G2/M phase in Orai3 overexpressing cells (P b 0.05).
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G2/M was observed in HEK203 cells strengthening the putative role
for Orai3 in the transition from mitosis. We therefore suggest that the
channel structure ismore important than its function to control cell pro-
liferation in the cell types used in this study. Supporting experiments
using truncated Orai1 or Orai3 proteins are now needed to establish
which parts of the channels are important in triggering cell prolifera-
tion. Orai1 or Orai3 channels may interact with proteins or kinases in-
volved in cell cycle independently of calcium ﬂuxes. TRPV1 can be
directly phosphorylated by CdK5 and inhibition of CdK5 activity by
roscovitine decreases TRPV1 function and Ca2+ inﬂux [44] or L-type
Cav1.2 activity [45]. InsP3 receptors also are likely to be regulated by
cyclin-dependent kinases [46,47]. However, to date, there is no evi-
dence for Orai1 or Orai3 interactions with any member of the cyclin/
cyclin-dependent kinase complexes.
Another tempting hypothesis is based on STIM1 and STIM2 potential
to bind several other intracellular proteins than Orai channels [48,49].
An increase or a decrease in Orai channels expression therefore may af-
fect the amount of STIM proteins available for alternative signaling
pathways. A domino like effect would even complicate data analysis
when the outputs are not direct as they are in SOCE activation for in-
stances but delayed in time when cell cycle is involved. Studies aimed
at identiﬁcation of associating partners of Orai and STIM proteins in
non-CRAC channel-related functions should greatly enhance our under-
standing of their physiological roles.
Frequency of [Ca2+]i transients is crucial in determining the speciﬁc-
ity of downstream cellular effectors [50,51]. The role of calcium inﬂux in
the control of this frequency is controversial. If it is recognized thatcalcium inﬂux plays a major role in controlling this frequency in
agonist-evoked Ca2+ signals [52,53], there is evidence showing that
these Ca2+ transients are observed in the presence of channel blockers
[54,55] or in Orai1 [56] or Orai3 [57] knock-down HEK293 cells. In our
experiments, cells are kept in the continuous presence of 10% fetal calf
serum and we have no evidence for spontaneous calcium transients in
these conditions, hence for SOCE activation. All together, these data
strongly suggest that Ca2+ inﬂux, whatever its nature, is not essential
for [Ca2+]i transients and for cell proliferation and that another source
of Ca2+ may be of major importance in these physiological responses.
Cell proliferation is also highly sensitive to ER Ca2+ content [58–60].
In our experimental conditions, Huh-7, HeLa and HEK293 cells, incubat-
ed for 72 h in a complete culture medium containing approximately
2 μM free Ca2+, had the same amount of intraluminal Ca2+ as in control
cells. Maintaining ER Ca2+ content could be obtained through an inhibi-
tion of ER Ca2+ leakage. The nature of the channel involved is not
established yet and includes a variety of ER proteins including
the translocon complex, polycystin-2, presenilins, members of anti-
apoptotic proteins of the Bcl2 and Bcl-2-associated X protein (Bax)-
inhibitor-1 (BI-1) families, and pannexins. They have all been report-
ed to produce an ER Ca2+ leak as part of their cellular mechanism [61].
In contrast, [Ca2+]i was signiﬁcantly reduced in all 3 cell types. Lower
[Ca2+]i may participate in ER channel regulation. InsP3 and ryanodine
receptors are less likely to open at low [Ca2+]i [62,63] and it is possible
that leak ER channels follow a similar behavior. Indeed, this is yet to be
proven but this would represent an interesting mean to maintain ER
Ca2+ content in cells kept in the absence of external Ca2+ for a long pe-
riod of time. In the same extent, calcium extrusion should be reduced at
471A.-S. Borowiec et al. / Biochimica et Biophysica Acta 1843 (2014) 464–472low [Ca2+]i as PMCA activity is decreased [64]. Altogether, it is likely
that the combination of all these effects led to cell survival at least
over the 3-day period of our study.
Knocking down Orai1 and Orai3 resulted in a clearer effect on cell
proliferation than on cell cycle arrest. Cell proliferation was slower but
not totally inhibited when both calcium channels were down-
regulated. The small but signiﬁcant rise in cell number in G2/Mobserved
in the absence of Orai3 and both Orai1 andOrai3, is probably underlying
a bottle-neck effect rather than a complete cell cycle arrest. Our results
showed that cells are still able to progress through mitosis but at a re-
duced rate. This is also probably due to the fact that both channels are
still present. We previously observed a 70% reduction in Orai1 expres-
sion in our experimental conditions [20] and our data showed that
Orai3 mRNA was also reduced by the same amount. Knocking-down
Orai1 had no effect on mRNA Orai3 levels and conversely (Supplemen-
tal Fig. 2). However, as cell proliferation is greatly reduced in siOrai3
condition, it is likely that Orai3 protein expression may also interfere
in the other cell cycle phases as the signiﬁcant increase in cell number
in G2/M phase is about 10%. The question now is to understand how
these two channels can control mitosis and cell cycle progression inde-
pendently of external calcium and therefore calcium inﬂux.
Recent work has demonstrated that many ion channels can directly
inﬂuence biochemical events in ways that do not directly depend on
their function as ion channels [65]. Although many signaling molecules
are known to associate with ion channels, the ﬁnding that an integral
element of the channel also catalyzes an enzymatic reaction or partici-
pates in cell–cell interactions strongly suggests that changes in channel
activity could inﬂuence these processes [65]. New functions for voltage-
gated Ca2+ channel auxiliary beta subunits have been recently identi-
ﬁed. These functions appear to be regulated by the beta subunit alone,
independently of any effects on the Ca2+ inﬂux; hence, the beta subunit
may not be truly “auxiliary” and may play more fundamental roles in
Ca2+ homeostasis or gene regulation [66,67]. More recently, a proteo-
lytic fragment of the C-terminus of the pore-forming subunit of L-type
channels (Cav1.2)was shown to act as a transcription factor [68]. For in-
stances, it is likely that the deletion of the N-term or C-term of Orai1
and Orai3 channels should provide valuable clues on the putative re-
gions linking channel expression and cell proliferation. It is therefore
possible that new functions for ORAI channels could be uncovered in
near future and that a direct link between the channel structure and
transcription factors would explain why some cells need the channel
more than the function to proliferate.
5. Conclusion
Cell proliferation is regulated by calcium channel expression al-
though it is insensitive to external calcium in several cell lines. This orig-
inal observation may imply additional functions for these proteins and
further experiments are now needed to reveal how they could interfere
with cell cycle progression and mitosis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.11.023.
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